Sun Pharmaceutical Industries today said the company and its arm entered into settlements with certain plaintiffs in an antitrust litigation matter currently pending in the United States.
"Sun Pharmaceutical Industries Ltd, and one of its wholly-owned subsidiaries have entered into settlements with certain plaintiffs in re Modafinil Antitrust Litigation matter currently pending in the United States District Court for the Eastern District of Pennsylvania," Sun Pharmaceutical Industries said in a BSE filing today.
According to the statement, the settlements extend to all claims brought by Apotex Corporation and the Retailer Purchaser Plaintiffs.
The terms of the settlements are confidential, it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
